The Filer, Tribute Pharmaceuticals Canada Inc., applied for a decision under the securities legislation of multiple jurisdictions that it is not a reporting issuer.
Following an amalgamation and arrangement, the Filer's outstanding securities were either exchanged for securities of the Acquiror or became exercisable for Acquiror shares.
The Filer had no intention to seek public financing and its common shares were delisted.
The Ontario Securities Commission, as principal regulator, granted the requested exemptive relief, allowing the Filer to cease being a reporting issuer.